Condition

The Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg

ClinicalTrials.gov condition label

Clinical trials1

Recruiting0

Common interventions2

Lead sponsors shown1

Clinical trials

1 shown

A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes MellitusNCT01245166 · 2010-11-01

UNKNOWN

Common interventions

AcarboseDRUG1Metformin/AcarboseDRUG1

Leading sponsors

Lotus Pharmaceutical1

Trial status mix

UNKNOWN1

Phase mix

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.